Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Thoracic Oncology

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/JTO.0b013e3182049d8bPMID 21258249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy.

  2011cited by this paper
• Statin medication use and the risk of biochemical recurrence after radical prostatectomy

  2010cited by this paper
• Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.

  2010cited by this paper
• Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.

  2010cited by this paper
• The LKB1–AMPK pathway: metabolism and growth control in tumour suppression

  2009cited by this paper
• Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.

  2009cited by this paper
• Mechanisms of double-strand break repair in somatic mammalian cells.

  2009cited by this paper
• AMPK in Health and Disease.

  2009cited by this paper
• Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells.

  2009cited by this paper
• The PI3-K/AKT-Pathway and Radiation Resistance Mechanisms in Non-small Cell Lung Cancer

  2009cited by this paper
• Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state

  2008cited by this paper
• Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck

  2008cited by this paper
• Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma

  2008cited by this paper
• A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia.

  2008cited by this paper
• p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK

  2008cited by this paper
• Statins in tumor suppression.

  2008cited by this paper
• Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans.

  2007cited by this paper
• In Vitro Mechanisms of Lovastatin on Lung Cancer Cell Lines as a Potential Chemopreventive Agent

  2007cited by this paper
• Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.

  2007cited by this paper
• Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.

  2006cited by this paper
• Rho GTPases: promising cellular targets for novel anticancer drugs.

  2006cited by this paper
• AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer

  2006cited by this paper
• Statin drugs and risk of advanced prostate cancer.

  2006cited by this paper
• Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling

  2006cited by this paper
• The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications

  2006cited by this paper
• Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo

  2006cited by this paper
• Blockage of Epidermal Growth Factor Receptor-Phosphatidylinositol 3-Kinase-AKT Signaling Increases Radiosensitivity of K-RAS Mutated Human Tumor Cells In vitro by Affecting DNA Repair

  2006cited by this paper
• Ras, PI(3)K and mTOR signalling controls tumour cell growth

  2006cited by this paper
• Statins and the risk of colorectal cancer.

  2005cited by this paper
• Radiation Oncology BioMed Central Review

  2005cited by this paper
• Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway.

  2005cited by this paper
• The potential of statins as part of anti-cancer treatment.

  2005cited by this paper
• Targeting the Mevalonate Pathway Inhibits the Function of the Epidermal Growth Factor Receptor

  2005cited by this paper
• PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas

  2005cited by this paper
• A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix.

  2005cited by this paper
• Blocking the Raf/MEK/ERK Pathway Sensitizes Acute Myelogenous Leukemia Cells to Lovastatin-Induced Apoptosis

  2004cited by this paper
• Lovastatin causes sensitization of HeLa cells to ionizing radiation‐induced apoptosis by the abrogation of G2 blockage

  2003cited by this paper
• The statins as anticancer agents.

  2003cited by this paper
• Effect of simvastatin on the uptake and metabolic conversion of palmitic, dihomo-gamma-linoleic and alpha-linolenic acids in A549 cells.

  2003cited by this paper
• Effect of simvastatin on the uptake and metabolic conversion of palmitic, dihomo-γ-linoleic and α-linolenic acids in A549 cells

  2003cited by this paper
• Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

  2002cited by this paper
• Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

  2002cited by this paper
• Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.

  2001cited by this paper
• Cell-cycle inhibitors: three families united by a common cause.

  2000cited by this paper
• Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines.

  2000cited by this paper
• Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.

  2000cited by this paper
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis*

  1998cited by this paper
• Effects of p21Cip1/Waf1 at Both the G1/S and the G2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication

  1998cited by this paper
• Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines

  1997cited by this paper
• Effects of ionizing radiation on cell cycle progression

  1995cited by this paper
• Aspirin and the risk of colorectal cancer in women.

  1995cited by this paper
• Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane.

  1994cited by this paper
• Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

  1991cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene.

  1986cited by this paper

• The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines

  2025cites this paper
• Molecular mechanisms underlying the effects of statins on bone metabolism: an evolving paradigm of statins delivery modalities for bone regeneration

  2025cites this paper
• AMPK: an energy sensor for Non-small cell lung cancer progression and treatment.

  2025cites this paper
• The Mevalonate Pathway in the Radiation Response of Cancer.

  2025cites this paper
• Targeting SREBP2 in cancer progression: Molecular mechanisms, oncogenic crosstalk, and therapeutic interventions.

  2025cites this paper
• Regulatory effects of statins on Akt signaling for prevention of cancers.

  2024cites this paper
• Anti-Inflammatory Effect of Atorvastatin on Primary Human Endothelial Cells Incubated under Genotoxic Load

  2024cites this paper
• Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma

  2023cites this paper
• Research Progress on Gene Synthesis and Anticancer and Lipid-lowering Mechanism of Monacolin K.

  2023cites this paper
• Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance

  2023cites this paper
• A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies

  2023cites this paper
• Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer

  2023influential citation
• Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C

  2023cites this paper
• Monacolin K Induces Apoptosis of Human Glioma U251 Cells by Triggering ROS-Mediated Oxidative Damage and Regulating MAPKs and NF-κB Pathways.

  2023cites this paper
• Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems

  2023cites this paper
• Repurposed Drugs in Gastric Cancer

  2022cites this paper
• Modulation of radiosensitivity of DU145 prostate carcinoma cells by simvastatin

  2022cites this paper
• A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer

  2022cites this paper
• Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role

  2022influential citation
• The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review

  2022cites this paper
• Molecular targets of statins and their potential side effects: Not all the glitter is gold.

  2022cites this paper
• Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer

  2022cites this paper
• Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis

  2021cites this paper
• Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis

  2021cites this paper
• Inhibitory effect of lovastatin on human lung cancer cell proliferation by regulating the ERK1/2 and COX-2 pathways

  2021cites this paper
• Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.

  2021cites this paper
• Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8.

  2021cites this paper
• Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a

  2020cites this paper
• Effects of the recurrence pattern on patient survival following SABR for stage I lung cancer

  2020cites this paper
• Ceramide-Enriched Membrane Domains Contribute to Targeted and Nontargeted Effects of Radiation through Modulation of PI3K/AKT Signaling in HNSCC Cells

  2020cites this paper
• Hypolipidemic effects and mechanisms of Val-Phe-Val-Arg-Asn in C 57 BL / 6 J mice and 3 T 3L 1 cell models

  2019cites this paper
• An overview of the bioactivity of monacolin K / lovastatin.

  2019cites this paper
• Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.

  2019cites this paper
• Statins: Complex outcomes but increasingly helpful treatment options for patients.

  2019cites this paper
• Statins and Lung Cancer: A Review of Current Literature

  2018cites this paper
• Simvastatin enhances radiation sensitivity of colorectal cancer cells

  2018cites this paper
• Identification of ATIC as a Novel Target for Chemoradiosensitization.

  2018cites this paper
• Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair

  2018cites this paper
• The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials

  2018cites this paper
• Effects of statins on the chemoresistance-The antagonistic drug-drug interactions versus the anti-cancer effects.

  2018cites this paper
• Aspects of Radiotherapy and its Impact on Radio Resistance and CellularMetabolic Activity

  2018cites this paper
• Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.

  2017cites this paper
• Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation

  2017cites this paper
• Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics.

  2016cites this paper
• A Randomized Controlled Open-Label Pilot Study of Simvastatin Addition to Whole-Brain Radiation Therapy in Patients With Brain Metastases

  2016cites this paper
• MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.

  2015cites this paper
• MEDICINAL SIGNIFICANCE OF LOVASTATIN

  2015cites this paper
• [Statins enhance anti-tumor effect of suberoylanilide hydroxamic acid on human non-small cell lung carcinoma cells].

  2015cites this paper
• Lipophilic Statins as Anticancer Agents: Molecular Targeted Actions and Proposal in Advanced Gynaecological Malignancies.

  2015cites this paper
• Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor.

  2015cites this paper
• Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again.

  2015cites this paper
• MCM 2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas

  2015influential citation
• The Role of p53 in Cetuximab Induced Radiosensitization of A549 Cells and the Mechanisms Involved

  2014cites this paper
• Combined cancer therapy with non-conventional drugs: all roads lead to AMPK.

  2014cites this paper
• HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model.

  2014influential citation
• Anticancer properties of Monascus metabolites

  2014cites this paper
• Novel prospects of statins as therapeutic agents in cancer.

  2014cites this paper
• AMP-activated protein kinase (AMPK) beyond metabolism

  2014cites this paper
• Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck

  2014influential citation
• Radiation Oncology In Vitro: Trends to Improve Radiotherapy through Molecular Targets

  2014cites this paper
• Statin Use and Risk of Lung Cancer: a Meta-Analysis of Observational Studies and Randomized Controlled Trials

  2013cites this paper
• Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK

  2013cites this paper
• Development of PI3K/AKT/mTOR signaling pathway and hypofractionated radiotherapy in non-small cell lung cancer

  2013cites this paper
• LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer.

  2013cites this paper
• Dynamic observation of the radiosensitive effect of irisquinone on rabbit VX2 lung transplant tumors by using fluorine-18-deoxyglucose positron emission tomography/computed tomography

  2013cites this paper
• LKB 1 / AMPK / mTOR Signaling Pathway in Non-small-cell Lung Cancer

  2013cites this paper
• To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer.

  2012cites this paper
• Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1.

  2012cites this paper
• Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival.

  2012cites this paper
• Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts

  2012cites this paper
• The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: a comprehensive review.

  2012cites this paper
• Sestrin2 Modulates AMPK Subunit Expression and Its Response to Ionizing Radiation in Breast Cancer Cells

  2012cites this paper
• Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma

  2012cites this paper
• Restoration of alveolar type II cell function contributes to simvastatin-induced attenuation of lung ischemia-reperfusion injury.

  2012cites this paper
• Targeting AMPK in the treatment of malignancies

  2012cites this paper